Company profile for Perspectum

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Perspectum® was founded in partnership with the University of Oxford in 2012 after a ground-breaking study demonstrated the potential of T1 mapping to predict liver fibrosis. New ways of accurately diagnosing liver disease early are essential if health care systems are to tackle this growing issue, which is predicted to lead to many more cases of serious liver damage and people needing liver transplants. Our work focuse...
Perspectum® was founded in partnership with the University of Oxford in 2012 after a ground-breaking study demonstrated the potential of T1 mapping to predict liver fibrosis. New ways of accurately diagnosing liver disease early are essential if health care systems are to tackle this growing issue, which is predicted to lead to many more cases of serious liver damage and people needing liver transplants. Our work focuses on the detection and accurate, quantitative measurement of liver, gallbladder and pancreatic disease, including precancerous and cancerous states.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Gemini One, 5520 John Smith Dr, Oxford OX4 2LL
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Arvo

Arvo

Not Confirmed

envelop Contact Supplier

Arvo

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20260105345411/en/Perspectum-and-Avant-Sant-Announce-Strategic-Partnership-to-Strengthen-Quantitative-Imaging-for-Metabolic-and-Liver-Research-in-Mexico-and-Latin-America

BUSINESSWIRE
05 Jan 2026

https://www.businesswire.com/news/home/20251201791795/en/Perspectum-and-InHealth-Announce-National-Diagnostics-Partnership-to-Boost-Oxford-CDC-Capacity-and-Widen-Access-to-Advanced-MRI-Across-the-UK

BUSINESSWIRE
02 Dec 2025

https://www.businesswire.com/news/home/20250318805633/en/New-Multinational-Study-Shows-MRI-is-Cost-Effective-in-the-Diagnosis-and-Management-of-Steatotic-Liver-Disease

BUSINESSWIRE
18 Mar 2025

https://www.businesswire.com/news/home/20241114522828/en

BUSINESSWIRE
14 Nov 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty